INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160024077A1
公开(公告)日:2016-01-28
The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.